Clyde:
still shows up at due diligence, and is not a good look.
It needs to be resolved to finalise any substantial deal, so no chance of " comeback" onto any buyer.
I agree no large pharma would buy the company, only the IP or individual product lines.
Below 1c by the end of the week?, page-38
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
-0.010(5.71%) |
Mkt cap ! $173.4M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 17.8¢ | 16.5¢ | $500.8K | 2.930M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1061663 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 92438 | 5 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| ALA (ASX) Chart |